openPR Logo
Press release

Ischemic Cerebral Stroke Prevention Therapeutics Market : Value Chain, Dynamics and Key Players (2017 - 2027)

05-30-2017 01:59 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Ischemic Cerebral Stroke Prevention Therapeutics Market :

When an obstruction occurs in the blood vessel that supplies blood to the brain, it is known as ischemic stroke. This stroke accounts for around 87 percent of the total stroke cases and the main cause leading to ischemic stroke is uncontrolled hypertension. Basically, ischemic stroke is due to weak blood vessel, which gets rupture and leads to blood spill into the brain tissue. There are two types of ischemic cerebral strokes namely embolic or thrombotic. During atherosclerosis, when artery is blocked by a blood clot, resulting into fatty deposits. However, when a blood clot is formed outside the brain and then travels to the blood stream, it is known as embolus (emboli) stroke. Globally, technological advancements leading to development of advanced surgical devices coupled with increasing prevalence of ischemic strokes among people has led to demand for better and efficient stroke management or treatment. Major goal of ischemic cerebral stroke prevention to restore flow of blood as quickly as possible. Conventional ischemic stroke treatments include intravenous thrombolytic therapy and intra-arterial mechanical thrombectomy, which includes stent retriever devices. According to American Stroke Association, few recommendations related to prevention of ischemic cerebral stroke include sleep apnea screening, smoking cessation, and usage of anticoagulants orally especially patients suffering with non-valvular atrial fibrillation.

It is essential to prevent the stroke as this is the deadly condition and is an age related. This can be basically controlled in two ways, Primary Prevention of Stroke and the other is Secondary Prevention of Stroke.

Primary Prevention of Stroke can be done with the administration of antihypertensive drugs, anticoagulants-warfarin; antiplatelet agents, and statins. The prominent cause of Ischemic Cerebral Stroke are smoking, hypertension, Diabetes, Sickle cell disease, Body fat etc. There are also some home primary remedies like self-monitoring of blood pressure in hypertensive patients and proper sleep.

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3236

Ischemic Cerebral Stroke Prevention Therapeutics Market: Drivers and Restraints

Increase in the number of cerebral stroke cases across the globe coupled with high prices for AIS therapy contribute towards significant growth of ischemic cerebral stroke prevention therapeutics market worldwide. In addition, growing prevalence of acute ischemic strokes among young population is anticipated to fuel the demand for surgical procedures, thereby in order to avoid the surgery demand for ischemic cerebral stroke prevention therapeutics will grow significantly in the next five to six years. However, limited availability of efficient drugs is restricting the market growth. Also, ischemic attack survivors are prone to another attack, thereby increased morbidity and mortality. This is leading to increased concerns for prevention therapeutics, resulting in overall ischemic cerebral stroke prevention therapeutics market growth.

Ischemic Cerebral Stroke Prevention Therapeutics Market: Segmentation

The global market for ischemic cerebral stroke prevention therapeutics is broadly classified on the basis of drug type, and end user.

Based on drug type, the ischemic cerebral stroke prevention therapeutics market has been segmented as follows:

Anticoagulation Therapy

Warfarin

Heparin

Revascularization

Reperfusion

Eminase

Retavase

Streptase

Others

Antiplatelet

Aspirin

Clopidogrel

Dipyridamole

Ticlopidine

Neuroprotective

Acetyl-L-carnitine

Citicoline (CDP-Choline)

Others

Based on end user, theischemic cerebral stroke prevention therapeutics market has been segmented as follows:

Hospitals

Clinics

Palliative Care

Ambulatory Surgery Centers

Ischemic Cerebral Stroke Prevention Therapeutics Market: Overview

The global ischemic cerebral stroke prevention therapeutics market is expected to expand at healthy CAGR owing to increasing awareness for prevention of ischemic cerebral strokes prevention across the world. Among end users, hospital end user segment is expected to account for maximum share due to requirement of advanced healthcare infrastructure and low cost.

Ischemic Cerebral Stroke Prevention Therapeutics: Region-wise Outlook

Geographically, the global intravenous ultrasound systems market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Among all the regions, North America will continue to lead the global market for ischemic cerebral stroke prevention therapeutics. This is attributed to increasing cerebral stroke cases in the region. Geriatric population in Europe and Asia Pacific, who are prone to cerebral stroke offer opportunity for ischemic cerebral stroke prevention therapeutics market in the regions.

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-3236

Ischemic Cerebral Stroke Prevention Therapeutics: Key Players

Key players operating in the global intravenous ultrasound systems market are Johnson & Johnson (Cordis Corporation), Boston Therapeutics, Inc., Edge Therapeutics, Inc., Zocere, Inc., Lundbeck, ThromboGenics, Vernalis, Bayer, Bristol-Myers Squibb, and Boehringer Ingelheim.

About Us – Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

CONTACT:
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ischemic Cerebral Stroke Prevention Therapeutics Market : Value Chain, Dynamics and Key Players (2017 - 2027) here

News-ID: 555870 • Views: 221

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases


More Releases for Stroke

Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Telemedicine Market - The Rising Number of Stroke
The global telemedicine market is anticipated to demonstrate promising growth in the coming years, according to a report published by Transparency Market Research (TMR). The market is characterized with the presence of a number of small and large players, and features a highly competitive environment. The leading vendors operating in the global telemedicine market are CISCO Systems, Inc., McKesson Corporation, Polycom Corp., and AMD Global Telemedicine. Vendors are expected to
7th International Conference on Neurological Disorders & Stroke
Greetings from Stroke Congress 2018!! We are writing to request all your presence to our CME accredited event as our eminent Speaker for the upcoming “7th International Conference on Neurological Disorders & Stroke (Stroke Congress 2018)” scheduled to be held on September 20-21, 2018 in Rome, Italy. The theme of the conference is Melioration in Innovations with advancement in Neurological disorders and Stroke to create awareness on the current needs &
Stroke Management Market By Application Ischemic Stroke and Hemorrhagic Stroke
The advancements in technology and facilities to diagnose stroke and discovery of novel drugs will drive growth of stroke management market. Technologies such as robotic-assisted angiography or exoskeleton soft suit for rehabilitation are the upcoming future of stroke management market. Moreover, an idea of Mobile Stroke Treatment Units (MSTU) was introduced in Germany in 2003 and was used in Berlin for the first time in 2008. The Prehospital Acute Neurological
Intracranial Stents Sales In Global Market, 2017: By Product Types - Ischemic St …
Researchmoz added Most up-to-date research on "Intracranial Stents Sales In Global Market, 2017: By Product Types - Ischemic Stroke & Hemorrhagic Stroke" to its huge collection of research reports. This report studies sales (consumption) of Intracranial Stents in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Medtronic Stryker MicroVention?Terumo? Abbott Balt Boston Scientific Obex Medical DePuy
Rising prevalence of ischemia stroke cases in Asia-Pacific Acute Ischemic Stroke …
“Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market" research report published by Market Data Forecast estimates that the market is growing with a CAGR of 7.9% to reach USD 507.758 million by 2021, from USD 356.726 million in 2016, which amounts to a cumulative growth of USD 151.03 million. Acute ischemic strokes imply the loss of brain function in certain parts created by the lack of blood supply to the brain.